Literature DB >> 7949101

Fluorescence in situ hybridization mapping of translocations and deletions involving the short arm of human chromosome 12 in malignant hematologic diseases.

H Kobayashi1, K T Montgomery, S K Bohlander, C N Adra, B L Lim, R S Kucherlapati, H Donis-Keller, M S Holt, M M Le Beau, J D Rowley.   

Abstract

Translocations and deletions of the short arm of chromosome 12 [t(12p) and del(12p)] are common recurring abnormalities in a broad spectrum of hematologic malignant diseases. We studied 20 patients and one cell line whose cells contained 12p13 translocations and/or 12p deletions using fluorescence in situ hybridization (FISH) with phage, plasmid, and cosmid probes that we previously mapped and ordered on 12p12-13. FISH analysis showed that the 12p13 translocation breakpoints were clustered between two cosmids, D12S133 and D12S142, in 11 of 12 patients and in one cell line. FISH analysis of 11 patients with deletions demonstrated that the deletions were interstitial rather than terminal and that the distal part of 12p12, including the GDI-D4 gene and D12S54 marker, was deleted in all 11 patients. Moreover, FISH analysis showed that cells from 3 of these patients contained both a del(12p) and a 12p13 translocation and that the affected regions of these rearrangements appeared to overlap. We identified three yeast artificial chromosome (YAC) clones that span all the 12p13 translocation breakpoints mapped between D12S133 and D12S142. They have inserts of human DNA between 1.39 and 1.67 Mb. Because the region between D12S133 and D12S142 also represents the telomeric border of the smallest commonly deleted region of 12p, we also studied patients with a del(12p) using these YACs. The smallest YAC, 964c10, was deleted in 8 of 9 patients studied. In the other patient, the YAC labeled the del(12p) chromosome more weakly than the normal chromosome 12, suggesting that a part of the YAC was deleted. Thus, most 12p13 translocation breakpoints were clustered within the sequences contained in the 1.39 Mb YAC and this YAC appears to include the telomeric border of the smallest commonly deleted region. Whether the same gene is involved in both the translocations and deletions is presently unknown.

Entities:  

Mesh:

Year:  1994        PMID: 7949101

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  8 in total

1.  AP-1 elements and TCL1 protein regulate expression of the gene encoding protein tyrosine phosphatase PTPROt in leukemia.

Authors:  Tasneem Motiwala; Nicola Zanesi; Jharna Datta; Satavisha Roy; Huban Kutay; Allyn M Checovich; Mohamed Kaou; Yiming Zhong; Amy J Johnson; David M Lucas; Nyla A Heerema; John Hagan; Xiaokui Mo; David Jarjoura; John C Byrd; Carlo M Croce; Samson T Jacob
Journal:  Blood       Date:  2011-10-14       Impact factor: 22.113

2.  Molecular allelokaryotyping of T-cell prolymphocytic leukemia cells with high density single nucleotide polymorphism arrays identifies novel common genomic lesions and acquired uniparental disomy.

Authors:  Daniel Nowak; Emilie Le Toriellec; Marc-Henri Stern; Norihiko Kawamata; Tadayuki Akagi; Martin J Dyer; Wolf-Karsten Hofmann; Seishi Ogawa; H Phillip Koeffler
Journal:  Haematologica       Date:  2009-03-10       Impact factor: 9.941

3.  Oligomerization of the ABL tyrosine kinase by the Ets protein TEL in human leukemia.

Authors:  T R Golub; A Goga; G F Barker; D E Afar; J McLaughlin; S K Bohlander; J D Rowley; O N Witte; D G Gilliland
Journal:  Mol Cell Biol       Date:  1996-08       Impact factor: 4.272

4.  Localization of the CDKN4/p27Kip1 gene to human chromosome 12p12.3.

Authors:  E Martin; V Cacheux; H Cavé; J M Lapierre; D Le Paslier; B Grandchamp
Journal:  Hum Genet       Date:  1995-12       Impact factor: 4.132

5.  Fusion of the TEL gene on 12p13 to the AML1 gene on 21q22 in acute lymphoblastic leukemia.

Authors:  T R Golub; G F Barker; S K Bohlander; S W Hiebert; D C Ward; P Bray-Ward; E Morgan; S C Raimondi; J D Rowley; D G Gilliland
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-23       Impact factor: 11.205

6.  Identification and characterization of OSTL (RNF217) encoding a RING-IBR-RING protein adjacent to a translocation breakpoint involving ETV6 in childhood ALL.

Authors:  Luciana M Fontanari Krause; Anna Sophia Japp; Alexandre Krause; Jana Mooster; Martin Chopra; Markus Müschen; Stefan K Bohlander
Journal:  Sci Rep       Date:  2014-10-09       Impact factor: 4.379

Review 7.  Myelodysplastic Syndrome: Diagnosis and Screening.

Authors:  Francisco P Tria; Daphne C Ang; Guang Fan
Journal:  Diagnostics (Basel)       Date:  2022-06-29

8.  Protein tyrosine phosphatase receptor-type O (PTPRO) exhibits characteristics of a candidate tumor suppressor in human lung cancer.

Authors:  Tasneem Motiwala; Huban Kutay; Kalpana Ghoshal; Shoumei Bai; Hiroyuki Seimiya; Takashi Tsuruo; Saul Suster; Carl Morrison; Samson T Jacob
Journal:  Proc Natl Acad Sci U S A       Date:  2004-09-08       Impact factor: 11.205

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.